GSK Licenses Companies to Make Cheap Copies of HIV Prevention Drug
March 31, 2023
(Reuters) – British drugmaker GSK has signed deals with three companies allowing them to make inexpensive generic versions of its long-acting HIV preventive medicine for use in lower-income countries, where the majority of new cases occur. (Read More)